FDA Clearance Tracker · DEN240035
ConcizuTrace ELISA
Last checked: Nov 20, 2026Latest source record: May 22, 2025 (this decision)Source: openFDAMethods & limitations
Decided
May 22, 2025
De Novo granted
Time to decision
325 days
Received Jul 1, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN240035
- Device name
- ConcizuTrace ELISA
- Applicant
- Randox Laboratories, Ltd.
- Applicant location
- Crumlin, GB
- Received
- Jul 1, 2024
- Decided
- May 22, 2025
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 864.7298
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for DEN240035
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Randox Laboratories, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ISE Electrodes510(k)
K230890 · Decided Sep 8, 2023 · 161 days after receipt
Device type: Electrode, Ion Specific, Potassium (CEM) · Laboratory Medicine & Pathology
- Randox Calcium (Ca)510(k)
K182042 · Decided Oct 23, 2018 · 85 days after receipt
Device type: Azo Dye, Calcium (CJY) · Laboratory Medicine & Pathology
K162200 · Decided Apr 28, 2017 · 266 days after receipt
Device type: Photometric Method, Magnesium (JGJ) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.